Quality of Life in Prostate Cancer Patients

Quality of Life in Prostate Cancer Patients: Challenges and Prospects for Reducing Disparities in the Caribbean

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04357925

Acronym

QoLProstateMQ

Enrollment

304

Registered

2020-04-22

Start date

2020-05-06

Completion date

2028-12-31

Last updated

2026-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate, Public Health, Quality of life

Brief summary

Recording cancer data in cancer registries is essential for producing reliable population-based data for service planning, monitoring and evaluation. Prostate cancer (PCa) remains the most frequent type of cancer in terms of incidence and mortality in men in the Caribbean. The quality of life PCa cohort will assess quality of life and patient outcomes in Martinique using a digital platform for patient-reported outcome measures.

Detailed description

The Martinique Cancer Registry database is the largest clinical database among the French population-based cancer registries in the Caribbean, including more than 38 000 cancer cases, with 1650 new cancer cases per year, including 550 new PCa cases per year (2010-2014 latest period). In 2020, follow-up will include vital status, assessment of quality of life with the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ) Core 30 and the Prostate cancer module QLQ-PR25. Urinary incontinence and erectile dysfunction recorded prior to treatment will be analysed 1, 3 and 5 years after treatment.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age\>18 years and residing in Martinique, with prostate cancer diagnosed from 2020 * The patient has provided informed consent * Patient with social security coverage

Exclusion criteria

* Refusal to participate * Patient with a second cancer, five years after diagnosis * Patient who could not answer the quality of life questionnaires * Patient not fluent in French * Person under legal protection

Design outcomes

Primary

Measure	Time frame	Description
Evaluation of overall Quality of Life: Questionnaire	At the date of diagnosis of the disease, at 1 year, 3 years and 5 years	Change of quality of life questionnaire related to sexual dysfunction

Countries

Martinique

Contacts

STUDY_DIRECTORClarisse CONTARET-JOACHIM

CHU Martinique

Outcome results